Effect of sodium valproate and baclofen in tardive dyskinesia: clinical and neuroendocrine studies
- PMID: 6773303
Effect of sodium valproate and baclofen in tardive dyskinesia: clinical and neuroendocrine studies
Abstract
Concurrent neuroleptic administration is a necessary factor in the therapeutic response to GABAergic agents. In contrast to their effect on the striatum, neither BAC nor NaV influences hypothalamic-pituitary DA function mediating PRL secretion.